Evidence map›Paper›PMID 28333320›Full record

ArticleThe Journal of antimicrobial chemotherapy2017

Cross-resistance to lincosamides, streptogramins A and pleuromutilins in Streptococcus agalactiae isolates from the USA.

Paulina A Hawkins, Caitlin S Law, Benjamin J Metcalf, Sopio Chochua, Delois M Jackson, Lars F Westblade, Robert Jerris, Bernard W Beall, Lesley McGee

Open access · hybridAbstract read
In one paragraph

Article in The Journal of antimicrobial chemotherapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Genomic Diversity, Virulome, and Resistome ofPathogens (Basel, Switzerland) · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Paulina A HawkinsRollins School of Public Health, Emory University, Atlanta, GA, USA.
Caitlin S LawCenters for Disease Control and Prevention, Atlanta, GA, USA.
Benjamin J MetcalfCenters for Disease Control and Prevention, Atlanta, GA, USA.
Sopio ChochuaCenters for Disease Control and Prevention, Atlanta, GA, USA.
Delois M JacksonCenters for Disease Control and Prevention, Atlanta, GA, USA.
Lars F WestbladeWeill Cornell Medical College, New York, NY, USA.
Robert JerrisChildren's Healthcare of Atlanta, Atlanta, GA, USA.
Bernard W BeallCenters for Disease Control and Prevention, Atlanta, GA, USA.
Lesley McGeeCenters for Disease Control and Prevention, Atlanta, GA, USA.
Centers for Disease Control and Prevention · USChildren's Healthcare of Atlanta · USCornell University · USEmory University · US

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

Background: Streptococcus agalactiae (Group B Streptococcus, GBS) is a leading cause of meningitis, sepsis and pneumonia in neonates in the United States. GBS also causes invasive disease in older infants, pregnant women, children and young adults with underlying medical conditions, and older adults. Resistance to lincosamides in the absence of erythromycin resistance is rare in GBS, but has been previously reported in clinical isolates, both on its own or in combination with resistance to streptogramins A and pleuromutilins (L/LSA/LSAP phenotypes). Objectives: To retrospectively screen the Active Bacterial Core surveillance (ABCs) GBS isolate collection for these phenotypes in order to identify the causal genetic determinants and determine whether their frequency is increasing. Methods: Based on MIC data, 65 (0.31%) isolates susceptible to erythromycin (MIC ≤0.25 mg/L) and non-susceptible to clindamycin (MIC ≥0.5 mg/L) were identified among 21 186 GBS isolates. Genomic DNA was extracted and WGS was performed. The presence of 10 genes previously associated with LSA resistance was investigated by read mapping. Results: Forty-nine (75%) isolates carried the lsa (C) gene and expressed the LSAP phenotype, and 12 (18%) carried both the lnu (B) and lsa (E) genes and expressed the LSAP phenotype. The four remaining isolates were negative for all determinants investigated. Conclusions: While the overall observed frequency of these phenotypes among our GBS isolates was quite low (0.31%), this frequency has increased in recent years. To the best of our knowledge, this is the first time the LSAP phenotype has been reported among GBS isolates from the USA.

Indexed as

AdultAnti-Bacterial AgentsChildClindamycinDiterpenesDrug Resistance, Multiple, BacterialEpidemiological MonitoringErythromycinFemaleHumansInfantInfant, NewbornLincosamidesMicrobial Sensitivity TestsPhenotypePleuromutilinsAnti-Bacterial AgentsClindamycinDiterpenesErythromycinLincosamidesPleuromutilinsPolycyclic CompoundsStreptogramins

Identifiers

PMID28333320
PMCPMC5733627
OpenAlexW2597357798

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.